Medical-biological Research of the Pathogenesis of COVID-19 Disease Caused by SARS-CoV-2
NCT04611841 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2020-11-02
Summary
Сonducting in-depth medical and biological studies of the pathogenesis of the disease caused by the SARS-CoV-2 in Moscow, the Moscow region and some other regions of the Russian Federation.
Conditions
- Covid19
Sponsors & Collaborators
-
Burnasyan Federal Medical Biophysical Center
collaborator OTHER_GOV -
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia
collaborator OTHER_GOV -
Moscow city hospital named after S.I. Spasokukotskiy
collaborator UNKNOWN -
Federal State Public Scientific Institution, Scientific Center for Family Health and Human Reproduction Problems
collaborator OTHER -
Federal State Budgetary Healthcare Institution, Hospital RAS
collaborator UNKNOWN -
Federal Research and Clinical Center of Physical-Chemical Medicine
lead OTHER
Principal Investigators
-
Vadim Govorun, MD · FRCC PCM
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-07-21
- Primary Completion
- 2022-12-31
- Completion
- 2022-12-31
Countries
- Russia
Study Locations
More Related Trials
-
Multiple-Center Retrospective Study of Severe and Critical COVID-19 in Shanghai
NCT05422963 ·Status: UNKNOWN
-
French COVID Cohort
NCT04262921 ·Status: ACTIVE_NOT_RECRUITING
-
EuRopean Study of MAjor Infectious Disease Syndromes Related to COVID-19
NCT04364711 ·Status: COMPLETED
-
SARS-CoV-2 Infection in COVID-19 Vaccinated Patients
NCT05060939 ·Status: COMPLETED ·Phase: NA
-
Study of "Sputnik Lite" for the Prevention of COVID-19 With Altered Antigenic Composition.
NCT06057025 ·Status: UNKNOWN ·Phase: PHASE3
-
Brazilian Registry for Clinical Presentation of Individuals With COVID-19 (SARS-Brazil)
NCT04479488 ·Status: COMPLETED
-
Correlation Between Cycle Threshold (Ct) Values in COVID-19, Health Status and Laboratory Biomarkers in the Population of Medellin- Colombia Evaluated in a Specialized Laboratory.
NCT05067920 ·Status: UNKNOWN
-
Ocular Complications of Mpox in the Democratic Republic Congo
NCT06579885 ·Status: COMPLETED
-
Viral Load Analysis of the SARS-CoV-2 Virus in Nose Versus Mouth Sites
NCT05769803 ·Status: UNKNOWN ·Phase: NA
-
Characteristics of COVID-19 Patients in Kazakhstan in Early 2020
NCT04627194 ·Status: UNKNOWN
-
Nasopharynx Microbiota Component and in Vitro Cytokines Production in Coronavirus Disease (COVID-19)
NCT04708912 ·Status: UNKNOWN
-
COVID-19 in Baselland: Validation of Simple and Accurate Tests for COVID-19 Detection, Monitoring and Tracing (ACCURATE-BL-COVID-19)
NCT04625257 ·Status: RECRUITING
-
Incidence, Associated Factors, and Burden of Post COVID-19 Condition in Brazil
NCT05822193 ·Status: RECRUITING
-
Effectiveness of COVID-19 Vaccines Against the SARS-COV-2 Delta (B.1.617.2)
NCT05244330 ·Status: COMPLETED
-
COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2
NCT04318314 ·Status: UNKNOWN
-
Microbial Infection and AMR in Hospitalized Patients With Covid 19
NCT04479982 ·Status: UNKNOWN
-
Microbiological Characterization and Nasal Carriage Rates of Methicillin Resistant Staphylococcus Aureus (MRSA) in Vancouver Downtown Eastside
NCT00247871 ·Status: COMPLETED
-
COVID-19 Vaccination AZV 2021-2023
NCT05589233 ·Status: COMPLETED
-
Evaluation of the Sofia SARS Antigen FIA Assay for COVID-19
NCT04953091 ·Status: UNKNOWN
-
Study of Specific Viral Immune Responses Induced by SARS-CoV-2 (COVID-19)
NCT04365322 ·Status: UNKNOWN
-
I VACCIN Hospitalization of COVID-19 Patients
NCT05244343 ·Status: COMPLETED
-
Dysbiosis & Long COVID
NCT06825819 ·Status: RECRUITING
-
Impact of Vaccination in Acute COVID-19
NCT05198453 ·Status: COMPLETED
-
Seasonal Factors and COVID 19
NCT05264948 ·Status: COMPLETED
-
Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care Workers
NCT04659941 ·Status: UNKNOWN ·Phase: PHASE2